EP2884964A4 - Composition pharmaceutique de propofol - Google Patents

Composition pharmaceutique de propofol

Info

Publication number
EP2884964A4
EP2884964A4 EP13833549.2A EP13833549A EP2884964A4 EP 2884964 A4 EP2884964 A4 EP 2884964A4 EP 13833549 A EP13833549 A EP 13833549A EP 2884964 A4 EP2884964 A4 EP 2884964A4
Authority
EP
European Patent Office
Prior art keywords
propofol
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13833549.2A
Other languages
German (de)
English (en)
Other versions
EP2884964A2 (fr
Inventor
Sougata Pramanick
Mukund Keshav Gurjar
Samit Satish Mehta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emcure Pharmaceuticals Ltd
Original Assignee
Emcure Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emcure Pharmaceuticals Ltd filed Critical Emcure Pharmaceuticals Ltd
Publication of EP2884964A2 publication Critical patent/EP2884964A2/fr
Publication of EP2884964A4 publication Critical patent/EP2884964A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP13833549.2A 2012-08-16 2013-08-13 Composition pharmaceutique de propofol Withdrawn EP2884964A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2373MU2012 2012-08-16
PCT/IN2013/000495 WO2014033751A2 (fr) 2012-08-16 2013-08-13 Composition pharmaceutique de propofol

Publications (2)

Publication Number Publication Date
EP2884964A2 EP2884964A2 (fr) 2015-06-24
EP2884964A4 true EP2884964A4 (fr) 2016-01-06

Family

ID=50184537

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13833549.2A Withdrawn EP2884964A4 (fr) 2012-08-16 2013-08-13 Composition pharmaceutique de propofol

Country Status (2)

Country Link
EP (1) EP2884964A4 (fr)
WO (1) WO2014033751A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104490780B (zh) * 2015-01-16 2017-04-19 河北一品制药有限公司 一种丙泊酚脂肪乳注射液的制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028108A (en) * 1998-10-22 2000-02-22 America Home Products Corporation Propofol composition comprising pentetate
WO2001089474A2 (fr) * 2000-05-25 2001-11-29 Astrazeneca Ab Formulation
US20030207946A1 (en) * 2002-05-02 2003-11-06 Fdl, Inc. Novel parenteral composition comprising propofol
WO2007052288A2 (fr) * 2005-08-05 2007-05-10 Bharat Serums & Vaccines Ltd. Compositions d'emulsion de propofol pour administration intraveineuse presentant une efficacite de conservation
WO2008049178A1 (fr) * 2006-10-27 2008-05-02 Cristália Produtos Químicos Farmacêuticos Ltda. Microémulsion huile dans l'eau de propofol, stable et prête à l'emploi
DE102009003980A1 (de) * 2009-01-07 2010-07-08 B. Braun Melsungen Ag Propofol in triheptanoinhaltiger Trägeremulsion
WO2010082092A1 (fr) * 2009-01-13 2010-07-22 Claris Lifesciences Limited Anesthésique à base de propofol contenant un conservateur

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
CN102552136B (zh) * 2012-02-09 2013-05-01 清远嘉博制药有限公司 一种丙泊酚中/长链注射液及其制备方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028108A (en) * 1998-10-22 2000-02-22 America Home Products Corporation Propofol composition comprising pentetate
WO2001089474A2 (fr) * 2000-05-25 2001-11-29 Astrazeneca Ab Formulation
US20030207946A1 (en) * 2002-05-02 2003-11-06 Fdl, Inc. Novel parenteral composition comprising propofol
WO2007052288A2 (fr) * 2005-08-05 2007-05-10 Bharat Serums & Vaccines Ltd. Compositions d'emulsion de propofol pour administration intraveineuse presentant une efficacite de conservation
WO2008049178A1 (fr) * 2006-10-27 2008-05-02 Cristália Produtos Químicos Farmacêuticos Ltda. Microémulsion huile dans l'eau de propofol, stable et prête à l'emploi
DE102009003980A1 (de) * 2009-01-07 2010-07-08 B. Braun Melsungen Ag Propofol in triheptanoinhaltiger Trägeremulsion
WO2010082092A1 (fr) * 2009-01-13 2010-07-22 Claris Lifesciences Limited Anesthésique à base de propofol contenant un conservateur

Also Published As

Publication number Publication date
WO2014033751A3 (fr) 2014-05-30
EP2884964A2 (fr) 2015-06-24
WO2014033751A2 (fr) 2014-03-06

Similar Documents

Publication Publication Date Title
HK1209638A1 (en) Pharmaceutical compositions
PL3181122T3 (pl) Kompozycja farmaceutyczna dazatynibu
ZA201501930B (en) Pharmaceutical composition
LT2854768T (lt) Pemetreksedo farmacinės kompozicijos
EP2832730A4 (fr) Composition pharmaceutique contenant du mirabegron
ZA201501928B (en) Pharmaceutical antiretroviral composition
EP2917314A4 (fr) Composition d'oligomère
DK2897594T3 (da) Farmaceutisk sammensætning
IL266415A (en) Innovative pharmaceutical composition
IL237139A0 (en) Pharmaceutical compositions of memantine
PL2887924T3 (pl) Kompozycje farmaceutyczne etorykoksybu
HK1210711A1 (en) Pharmaceutical composition comprising rebamipide
ZA201502987B (en) Pharmaceutical composition
RS55291B1 (sr) Farmaceutska kompozicija koja sadrži fosfolipid
EP2897590A4 (fr) Composition pharmaceutique
GB201211153D0 (en) Pharmaceutical compositions
EP2851074A4 (fr) Composition pharmaceutique analgésique
EP2884964A4 (fr) Composition pharmaceutique de propofol
EP2851078A4 (fr) Composition pharmaceutique
IL238075A0 (en) pharmaceutical preparations
ZA201400751B (en) Pharmaceutical composition
GB201221130D0 (en) New pharmaceutical composition
GB201207628D0 (en) New pharmaceutical composition
GB201207701D0 (en) New pharmaceutical composition
GB201219234D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150316

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20151209

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101ALI20151203BHEP

Ipc: A61K 31/05 20060101ALI20151203BHEP

Ipc: A61K 9/107 20060101AFI20151203BHEP

Ipc: A61P 23/00 20060101ALI20151203BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20181108

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200303